Table 3.

Sensitivity analysis of the association between the TyG index and ASCVD events or all-cause mortality

Variables	Per unit increase	Quartile 1	Quartile 2	Quartile 3	Quartile 4	P for trend
ASCVD events	1.20 (1.12–1.28)	Reference	1.25 (1.06–1.49)	1.35 (1.15–1.60)	1.63 (1.06–1.49)	< 0.001
MI	1.37 (1.16–1.62)	Reference	1.60 (0.95–2.67)	2.44 (1.51–3.95)	2.75 (1.69–4.48)	< 0.001
IS	1.05 (0.96–1.16)	Reference	1.20 (0.97–1.49)	1.21 (0.98–1.50)	1.23 (0.99–1.53)	0.062
Revascularization therapy	1.41 (1.27–1.57)	Reference	1.40 (1.03–1.90)	1.62 (1.21–2.17)	2.41 (1.81–3.21)	< 0.001
All-cause mortality	1.16 (1.07–1.26)	Reference	1.17 (0.97–1.41)	1.21 (1.00-1.45)	1.43 (1.19–1.73)	0.001

Model was adjusted for age, sex, educational background, smoking status, drinking status, snoring, BMI, SBP, history of hypertension, history of diabetes mellitus, family history of CVD, use of antidiabetic agents, lipid-lowering agents, antihypertensive agents, TC, HDL-C, LDL-C, hs-CRP and the TyG index

ASCVD atherosclerotic cardiovascular disease, MI myocardial infarction, IS ischemic stroke, BMI body mass index, SBP systolic blood pressure, CVD cardiovascular disease, TC total cholesterol, HDL-C high density lipoproteincholesterol, LDL-C low density lipoproteincholesterol, hs-CRP high sensitivity C-reactive protein, TyG index triglyceride-glucose index